Skip to main content

Table 2 Predominant cell type infiltrating tumour stroma and number of patients in each group

From: Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma

Predominant cell type infiltrating tumour stroma

Number (%)

Survival days (IQR)

Lymphocytic

92 (78%)

368 (198–689)

Neutrophilic

10 (8%)

233 (74–375)

Equal

9 (8%)

204 (108–380)

Acellular

7 (6%)

258 (108–562)